Seven Eight Capital LP Makes New $433,000 Investment in Azenta, Inc. (NASDAQ:AZTA)

Seven Eight Capital LP purchased a new position in Azenta, Inc. (NASDAQ:AZTA) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 8,234 shares of the company’s stock, valued at approximately $433,000.

A number of other hedge funds also recently modified their holdings of the business. Hantz Financial Services Inc. acquired a new position in shares of Azenta in the 2nd quarter valued at approximately $30,000. Principal Securities Inc. acquired a new position in shares of Azenta in the fourth quarter valued at approximately $36,000. Benjamin F. Edwards & Company Inc. bought a new stake in shares of Azenta during the first quarter worth $38,000. BI Asset Management Fondsmaeglerselskab A S acquired a new stake in shares of Azenta during the first quarter worth $49,000. Finally, Lazard Asset Management LLC bought a new stake in Azenta in the 1st quarter valued at $130,000. Institutional investors and hedge funds own 99.08% of the company’s stock.

Analyst Ratings Changes

A number of research firms have issued reports on AZTA. Needham & Company LLC reiterated a “buy” rating and set a $69.00 target price on shares of Azenta in a report on Wednesday, August 7th. Evercore ISI increased their price objective on Azenta from $52.00 to $53.00 and gave the stock an “in-line” rating in a report on Tuesday, July 2nd. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, Azenta presently has a consensus rating of “Hold” and a consensus price target of $67.00.

Azenta Trading Down 0.5 %

Shares of AZTA stock opened at $49.27 on Monday. The firm’s fifty day moving average price is $52.36 and its two-hundred day moving average price is $53.85. Azenta, Inc. has a 1 year low of $44.00 and a 1 year high of $69.16. The firm has a market capitalization of $2.66 billion, a P/E ratio of -18.18 and a beta of 1.47.

Azenta (NASDAQ:AZTA) last released its earnings results on Tuesday, August 6th. The company reported $0.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.07 by $0.09. Azenta had a positive return on equity of 0.89% and a negative net margin of 23.66%. The business had revenue of $173.00 million for the quarter, compared to the consensus estimate of $166.14 million. During the same quarter in the previous year, the business earned $0.13 earnings per share. Azenta’s quarterly revenue was up 4.2% on a year-over-year basis. As a group, equities research analysts forecast that Azenta, Inc. will post 0.33 EPS for the current fiscal year.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.